Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-α-difluoromethylornithine

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 973-978

  Merali, Salim ^a   Clarkson Jr , Allen B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 0029868424     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.973     Document Type: Article

References (41)

1. 12-bis(ethyl)spermine. Biochem. J. 291:131-137.
2. Arundel, C, M., K. Nishioka, and P. J. Tofilon. 1988. Effects of α-difluoro-methylornithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line. Radiat. Res. 114:634-640.
3. Bacchi, C. J., H. C. Nathan, S. H. Hutner, P. P. McCann, and A. Sjoerdsma. 1980. Polyamine metabolism: a potential target in trypanosomes. Science 210:332-334.
4. Bacchi, C. J., and N. Yarlett. 1993. Effects of antagonists of polyamine metabolism on African trypanosomes. Acta Trop. 54:225-236.
5. Bey, P. B., C. Danzin, and M. Jung. 1987. Inhibition of basic amino acid decarboxylases involved in polyamine biosynthesis, p. 1-31. In P. McCann, A. E. Pegg, and A. Sjoerdsma (ed.), Inhibition of polyamine metabolism. Academic Press, New York.
6. Bitonti, A. J., C. J. Bacchi, P. P. McCann, and A. Sjoerdsma. 1985. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effect on murine trypanosomiasis. Biochem. Pharmacol 34:1773-1777.
7. Byers, T. L., and A. E. Pegg. 1989. Properties and physiological function of the polyamine transport system. Am. J. Physiol. 257:C545-C553.
8. Clarkson, A. B., M. Saric, and R. W. Grady. 1990. Deferoxamine and eflornithine (DL-α-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 34:1833-1835.
9. Clarkson, A. B., Jr., D. E. Williams, and C. Rosenberg. 1988. Efficacy of DL-α-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 32:1158-1163.
10. Cushion, M. T., D. Stanforth, M. J. Linke, and P. D. Walzer. 1985. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrob. Agents Chemother. 28:796-801.
11. Davey, R. T., Jr. and H. Masur. 1990. Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 34:499-504.
12. Gerner, E. W., and P. S. Mamont. 1986. Restoration of the polyamine contents in rat hepatoma tissue-culture cells and inhibition of polyamine biosynthesis. Eur. J. Biochem. 156:31-35.
13. Giffin, B. F., P. P. McCann, A. J. Bitonti, and C. J. Bacchi. 1986. Polyamine depletion following exposure to DL-α-difloromethylornithine both in vivo and in vitro initiates morphological alteration and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei. J. Protozool. 33:238-243.
14. Golden, J. A., A. Sjoerdsma, and D. V. Santi. 1984. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. West. J. Med. 141: 613-623.
15. Griffin, C. A., M. Slavik, S. C. Chien, J. Hermann, G. Tholpson, O. Blane, G. D. Luk, S. B. Baylin, and M. D. Abeloff. 1987. Phase I trial and pharmacokinetic study of intravenous and oral α-difluoromethylornithine. Invest. New Drugs 5:177-186.
16. Grossie, V. B., D. M. Ota, J. A. Ajani, and K. Nishioka. 1987 Effect of intravenous α-difluoromethylornithine on polyamine levels of normal tissue and a transplantable fibrosarcoma. Cancer Res. 47:1836-1840.
17. Holtta, E., P. Hannonen, J. Pispa, and J. Janne. 1973 Effect of methyl-glyoxal bis(guanylhydrazone) on polyamine metabolism in normal and regenerating rat liver and rat thymus. Biochem. J 136:669-676.
18. Hughes, W. T., and B. L. Smith. 1984. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 26:436-440
19. Kovacs, J. A., J. W. Hiemenz, A. M. Marcher, D. Stover, H. W. Murray, J. Shelhamer, H. C. Lane, C. Urmarchjer, C. Honing, D. Longo, M. M. Parker, J. E. Natanson, J. E. Parillo, A. S. Fauci, P. A. Piazzo, and H. Masur. 1984. Pneumocystis carinii pneumonia: a comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100:663-671.
20. Lipschik, G. Y., H. Masur, and J. A. Kovacs. 1991. Polyamine metabolism in Pneumocystis carinii J. Infect. Dis. 163:1121-1127
21. Merali, S., K. Chin, R. W. Grady, L. Weissberger, and A. B. Clarkson, Jr. 1995 Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine. Antimicrob. Agents Chemother. 39:1442-1444.
22. Merali, S., and A. B. Clarkson. 1996. Polyamine analysis using N-hydroxysuccinimidyl-6-aminoquinoyl carbamate (AccQ.Fluor) for pre-column derivatization J. Chromatogr. B 675:321-326.
23. Nakaike, S., K. Nashiwagi, K. Terao, K. Lio, and K. Igarashi. 1988. Combined use of α-difluoromethylornithine and an inhibitor of S-adenosylmethionine decarboxylase in mice bearing P388 leukemia or Lewis lung carcinoma. Jpn. J Cancer Res. 79:501-508.
24. Paulson, Y. J., T. M. Gilman, P. N. R. Heseltine, O. P. Sharma, and C. T. Boylen. 1992 Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Chest 101:67-74.
25. Pegg, A. E. 1989. Characteristics of ornithine decarboxylase from various sources, p. 21-45. In S -I. Hayashi (ed.), Ornithine decarboxylase: biology, enzymology and molecular genetics. Pergamon Press, New York.
26. Pegg, A. E., and P. P. McCann. 1982. Polyamine metabolism and function. Am. J. Physiol. 243:C212-C221.
27. Pegg, A. E., and P. P. McCann. 1988. Polyamine metabolism and function in mammalian cells and protozoans. p 11-17 In ISI Atlas Biochem. Institute for Scientific Information, Philadelphia
28. Pegg, A. E., H. Poso, K. Shuttleworth, and R. A. Bennett. 1982 Effect of inhibition of polyamine synthesis on the content of decarboxlated S-adenosylmethionine Biochem J 202:519-526.
29. Pesanti, E. L., M. S. Bartlett, and J. W. Smith. 1988. Lack of detectable activity of ornithine decarboxylase in Pneumocystis carinii. J. Infect. Dis. 158:1137-1138.
30. Pfaller, M. A., H. Riley, and T. Gerarden. 1988. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by α-difluoromethylornithine and cyclohexylamine. J. Med. Vet. Mycol. 26:119-126.
31. Pfaller, M. A., H. Riley, and T. Gerarden. 1990. Polyamine depletion and growth inhibition of Cryptococcus neoformans by α-difluoromethylornithine and cyclohexylamine. Mycopathologia 112:27-32.
32. Romijn, J. C., C. F. Verdoelin, and T. A. W. Splinter. 1987. Problems of pharmacokincetic studies on alpha-difluoromethylornithine in mice. Cancer Chemother. Pharmacol. 19:30-34.
33. Saric, M., and A. B. Clarkson. 1994. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy. Antimicrob. Agents Chemother. 38:2545-2552.
34. Schechter, P. J., J. L. R. Barlow, and A. Sjoerdsma. 1987. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases, p. 345-364. In P McCann, A. E. Pegg, and A. Sjoerdsma (ed), Inhibition of polyamine metabolism. Academic Press, New York.
35. Seiler, N. 1990. Polyamine metabolism. Digestion 46(Suppl. 2):319-330.
36. Sjoerdsma, A., and P. J. Schechter. 1984. Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin. Pharmacol. Ther. 35:287-300.
37. Smith, D. E., S. Davies, J. Smithson, I. Harding, and B, G. Gazzard. 1992. Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients. AIDS 6:1489-1493.
38. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53: 749-790.
39. Thomas, T., and T. J. Thomas. 1993. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res. Treat. 29:189-201.
40. Van Nieuwenhove, S. 1992. Advances in sleeping sickness therapy. Ann. Soc Belge Med. Trop. 72(Suppl. 1):39-51.
41. Vöhringer, H.-F., and K. Arastéh. 1993. Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia. Clin. Pharmacokinet. 24:388-412.